J Physiol Society Meetings
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Physiol Vol 460 pp 221-229
Copyright © 1993 by The Physiological Society
This Article
Right arrow Full Text (PDF)
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Morimoto, A
Right arrow Articles by Murakami, N
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morimoto, A
Right arrow Articles by Murakami, N

The central role of corticotrophin-releasing factor (CRF-41) in psychological stress in rats.

A Morimoto, T Nakamori, K Morimoto, N Tan and N Murakami

Department of Physiology, Yamaguchi University School of Medicine, Japan.

1. We investigated the central role of corticotrophin-releasing factor (CRF-41) in psychological stress-induced responses, including cardiovascular, thermoregulatory and locomotive activity in free-moving rats. 2. Psychological stress was induced by cage-switch stress. After rats were placed in the novel environment, blood pressure, heart rate, body temperature and locomotive activity significantly increased. The intracerebroventricular (I.C.V.) injection of alpha-helical CRF(9-41), a CRF-41 receptor antagonist, significantly attenuated the stress-induced hypertension, tachycardia, hyperthermia and increase in locomotive activity. However, in unstressed rats, the I.C.V. injection of alpha-helical CRF(9-41) had no effect on physiological parameters measured in this study. 3. In unstressed rats, the I.C.V. injection of CRF-41 (1 microgram and 10 micrograms) increased blood pressure, heart rate, body temperature and locomotive activity in a dose-dependent manner. The changes in these responses were quite similar to those observed during cage-switch stress. 4. The results suggest that central CRF-41 plays an important role in psychological stress-induced hypertension, hyperthermia, tachycardia and increase in locomotive activity. However, it is likely that central CRF-41 does not contribute to normal cardiovascular and body temperature regulation when rats are free from stress.




This article has been cited by other articles:


Home page
Evid Based Complement Alternat MedHome page
L. Wang, G. Muxin, H. Nishida, C. Shirakawa, S. Sato, and T. Konishi
Psychological Stress-Induced Oxidative Stress as a Model of Sub-Healthy Condition and the Effect of TCM
Evid. Based Complement. Altern. Med., June 1, 2007; 4(2): 195 - 202.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
D. L. Lee, R. C. Webb, and M. W. Brands
Sympathetic and angiotensin-dependent hypertension during cage-switch stress in mice
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2004; 287(6): R1394 - R1398.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. Morimoto, Y. Kurahashi, K. Shintani-Ishida, N. Kawamura, M. Miyashita, M. Uji, N. Tan, and K.-i. Yoshida
Estrogen replacement suppresses stress-induced cardiovascular responses in ovariectomized rats
Am J Physiol Heart Circ Physiol, November 1, 2004; 287(5): H1950 - H1956.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
D. L. Lee, R. Leite, C. Fleming, J. S. Pollock, R. C. Webb, and M. W. Brands
Hypertensive Response to Acute Stress Is Attenuated in Interleukin-6 Knockout Mice
Hypertension, September 1, 2004; 44(3): 259 - 263.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
U. Shalev, J. W. Grimm, and Y. Shaham
Neurobiology of Relapse to Heroin and Cocaine Seeking: A Review
Pharmacol. Rev., March 1, 2002; 54(1): 1 - 42.
[Abstract] [Full Text] [PDF]


Home page
Psychosom. Med.Home page
T. Oka, K. Oka, and T. Hori
Mechanisms and Mediators of Psychological Stress-Induced Rise in Core Temperature
Psychosom Med, May 1, 2001; 63(3): 476 - 486.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
H. E. W. Day, A. Badiani, J. M. Uslaner, M. M. Oates, N. M. Vittoz, T. E. Robinson, S. J. Watson Jr, and H. Akil
Environmental Novelty Differentially Affects c-fos mRNA Expression Induced by Amphetamine or Cocaine in Subregions of the Bed Nucleus of the Stria Terminalis and Amygdala
J. Neurosci., January 15, 2001; 21(2): 732 - 740.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. Okuyama, S. Chaki, N. Kawashima, Y. Suzuki, S.-I. Ogawa, A. Nakazato, T. Kumagai, T. Okubo, and K. Tomisawa
Receptor Binding, Behavioral, and Electrophysiological Profiles of Nonpeptide Corticotropin-Releasing Factor Subtype 1 Receptor Antagonists CRA1000 and CRA1001
J. Pharmacol. Exp. Ther., May 1, 1999; 289(2): 926 - 935.
[Abstract] [Full Text]


Home page
J. Neurosci.Home page
A. Badiani, M. M. Oates, H. E. W. Day, S. J. Watson, H. Akil, and T. E. Robinson
Amphetamine-Induced Behavior, Dopamine Release, and c-fos mRNA Expression: Modulation by Environmental Novelty
J. Neurosci., December 15, 1998; 18(24): 10579 - 10593.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
V. Martínez, J. Rivier, L. Wang, and Y. Taché
Central Injection of a New Corticotropin-Releasing Factor (CRF) Antagonist, Astressin, Blocks CRF- and Stress-Related Alterations of Gastric and Colonic Motor Function
J. Pharmacol. Exp. Ther., February 1, 1997; 280(2): 754 - 760.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1993 The Physiological Society.